The 2020-2021 Submission Cycle is now closed.
Applicants selected for the Finalist round will be notified by mid-February.
Finalist Presentations will take place on March 3.

Creating a stronger, more equitable New York by bridging promising translational research to marketplace and commercial success
The X-Seed Award was created by Deerfield as a result of the partnership announced in September 2019 between NYCEDC and Deerfield to develop the Cure life sciences campus, which is slated to open in January 2021. The 12-story vertical campus is bringing together innovators from academia, government, industry, and the not-for-profit sectors under one roof to advance human health and accelerate the fight against disease.

Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit


James Flynn
Claire Pomeroy
Nancy Thornberry
Elise Wang
Joseph Pearlberg


Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders

Proposal Submission

Applicants interested in the XSeed Grant Award will complete an online Letter of Intent addressing: Novelty, Genetics and Biologic Rationale.

A one-page Non-Confidential Executive Summary outlining the specific aims of the project should be included with the Letter of Intent submission.

2020 – 2021 Key Research Focus – Infectious Disease

The 2020-2021 submission cycle will close on January 29, 2021 at 11:59 PM EST.

All information provided in the proposal submission is non-confidential.

To view more details about the application and/or submit a proposal, please click here.


* is required field.

Error sending form, please try again.